SAN DIEGO, April 20, 2016 /PRNewswire/ -- Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Hansen Medical, Inc. (NASDAQ: HNSN) breached their fiduciary duties in connection with the proposed sale of the Company to Auris Surgical Robotics, Inc.
Hansen develops, manufactures and sells medical robotics designed for the positioning, manipulation, and control of catheters and catheter-based technologies.
On April 20, 2016, Hansen announced it had signed a definitive merger agreement Auris Surgical. Under the terms of the agreement, Hansen stockholders will be acquired for $4.00 per share in an all-cash transaction.
The investigation concerns whether the Hansen board failed to satisfy their duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Hansen shares of common stock. Nationally recognized Johnson & Weaver is investigating whether the proposed deal price represents adequate consideration. Hansen's 52 week high is $12.20.
If you are a shareholder of Hansen and believe the proposed buyout price is too low or you're interested in learning more about the investigation or your legal rights and remedies, please contact lead analyst Jim Baker (firstname.lastname@example.org) at 619-814-4471. If emailing, please include a phone number where you can be reached.
About Johnson & Weaver, LLP:
Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.
Johnson & Weaver, LLP
Jim Baker, 619-814-4471
SOURCE Johnson & Weaver, LLP